Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
A complete digital device inside digital well being information results in extra sufferers receiving the really helpful screenings for lung most cancers, in...
This text is for informational functions solely and isn't an alternative to skilled medical recommendation, prognosis or remedy. Contact a professional medical skilled...
